LYFCX Mutual Fund
LYFCX Mutual Fund
LYFCX Mutual Fund
AlphaCentric Life Sciences and Healthcare Fund Class C
LYFCX Mutual Fund Overview
LYFCX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class C) is managed by Alpha Centric Fund with $2.1M in net assets. LYFCX expense ratio is 2.46%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.
LYFCX performance shows a YTD return of 12.86%. The 1-year return is 49.52% and the 5-year return is 8.13%. LYFCX dividend yield stands at 0.66%, paid annually.
LYFCX top holdings include Gilead Sciences (5.5%), Nvaesrtex Pharmaceuticals Inc (5.3%), Astrazeneca Plc (4.6%), First Am Treas Obli-X (4.3%), Roivant Sciences Ltd. Common Shares (3.7%). Go to all LYFCX holdings, LYFCX sectors, or LYFCX dividends.
LYFCX can be compared against other funds. Use LYFCX overlap to find shared positions, or LYFCX vs another fund for a side-by-side view. LYFCX alternatives are available via the screener, along with tax-loss harvesting opportunities.